Lambda’s Clinical Laboratory in Ahmedabad has successfully completed its recent inspection by the College of American Pathologists (CAP), with accreditation now valid till 01 March 2028.
The laboratory has maintained continuous CAP accreditation since 2005, reflecting sustained compliance with global quality standards in clinical and bioanalytical testing. This continuity supports reliable data generation across clinical studies.
Lambda’s Central Clinical Laboratory supports clinical trials across all phases, offering integrated testing services through standardized processes and quality controlled systems.
Core Capabilities:
- Biomarkers
- Assay Development
- Safety Testing
- Hematology
- Cytology
- Biochemistry
- Immunology and Serology
- Molecular Biology
- Microbiology
- Coagulation Studies
- Microbiological testing for healthcare and hygiene products
Validated LIMS ensures data integrity and efficient sample management, with pan-India logistics enabling timely and controlled sample handling.
The laboratory operates under globally accepted quality frameworks and holds accreditations including CAP and NABL. Processes are aligned with regulatory expectations to support clinical trial submissions across major markets. Consistent CAP accreditation since 2005 demonstrates a sustained approach to quality, accuracy, and operational reliability.
As a full-service global CRO, Lambda Therapeutic Research provides comprehensive clinical research services for pharmaceutical, biotech, and generic organisations worldwide. For more information about our capabilities or facility accreditations, please contact bd@lambda-cro.com.
